Last updated 2026-06-18
- Raised $2M funding round, Sep 2022
Total raised
$2.0M
Last: 2022-09
Stage
Seed
Founded
2022
Headcount
0
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
OMEC.AI's mission is to help pharmaceutical companies have better chances in clinical trials by making better data-driven decisions in the pre-clinical process. The company provides an automated, data-focused solution that can produce a reliable assessment of the clinical trial-readiness of a proposed drug. OMEC.AI was established with funding and support from AION Labs, a collaboration between pharmaceutical giants Pfizer, AstraZeneca, Merck, and Teva Pharmaceuticals, together with Amazon's AWS and the Israel Biotech Fund.
Funding history · 1 round · $2.0M total
2022-09
Q&A
- What is OMEC.AI's primary mission?
- OMEC.AI's mission is to assist pharmaceutical companies in improving their success rates in clinical trials by enabling better data-driven decisions during the pre-clinical process.
- What solution does OMEC.AI provide?
- OMEC.AI offers an automated, data-focused solution designed to produce a reliable assessment of a proposed drug's readiness for clinical trials.
- When was OMEC.AI founded?
- OMEC.AI was founded in September 2022.
- What is OMEC.AI's current operational status?
- OMEC.AI is currently inactive, having ceased operations in July 2023.
- How much funding has OMEC.AI raised in total?
- OMEC.AI has raised a total of $2,000,000.
- Which investors participated in OMEC.AI's funding round?
- OMEC.AI received funding and support from AION Labs and Israel Innovation Authority.
- What is OMEC.AI's primary sector?
- OMEC.AI's primary sector is Health Tech & Life Sciences.
- What technologies does OMEC.AI utilize?
- OMEC.AI utilizes Artificial Intelligence.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesPharmaceuticals
Business model
B2C
Tags
biopharmaceuticalartificial-intelligenceclinical-trialsdrug-developmentdrug-discovery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2022-9 |
|---|---|
| Status reason | Non Active, Jul 2023 ceased to operate |